Genetic characterization of the human relapsing fever spirochete Borrelia miyamotoi in vectors and animal reservoirs of Lyme disease spirochetes in France
© Cosson et al.; licensee BioMed Central Ltd. 2014
Received: 24 March 2014
Accepted: 2 May 2014
Published: 20 May 2014
In France as elsewhere in Europe the most prevalent TBD in humans is Lyme borreliosis, caused by different bacterial species belonging to Borrelia burgdorferi sensu lato complex and transmitted by the most important tick species in France, Ixodes ricinus. However, the diagnosis of Lyme disease is not always confirmed and unexplained syndromes occurring after tick bites have become an important issue. Recently, B. miyamotoi belonging to the relapsing fever group and transmitted by the same Ixodes species has been involved in human disease in Russia, the USA and the Netherlands. In the present study, we investigate the presence of B. miyamotoi along with other Lyme Borreliosis spirochetes, in ticks and possible animal reservoirs collected in France.
We analyzed 268 ticks (Ixodes ricinus) and 72 bank voles (Myodes glareolus) collected and trapped in France for the presence of DNA from B. miyamotoi as well as from Lyme spirochetes using q-PCR and specific primers and probes. We then compared the French genotypes with those found in other European countries.
We found that 3% of ticks and 5.55% of bank voles were found infected by the same B. miyamotoi genotype, while co-infection with other Lyme spirochetes (B. garinii) was identified in 12% of B. miyamotoi infected ticks. Sequencing showed that ticks and rodents carried the same genotype as those recently characterized in a sick person in the Netherlands.
The genotype of B. miyamotoi circulating in ticks and bank voles in France is identical to those already described in ticks from Western Europe and to the genotype isolated from a sick person in The Netherlands. This results suggests that even though no human cases have been reported in France, surveillance has to be improved. Moreover, we showed that ticks could simultaneously carry B. miyamotoi and Lyme disease spirochetes, increasing the problem of co-infection in humans.
Human pathogenic Borrelia species are comprised of two main groups of spirochetes: the Lyme borreliosis group which cause human Lyme diseases, are widespread throughout Europe, Asia and North America and are transmitted between vertebrates by hard ticks (genus Ixodes); and the group causing severe relapsing fever in humans and which are transmitted by both, soft and hard ticks. Borrelia miyamotoi, belonging to the relapsing fever group, is transmitted by the same Ixodes species that also transmits Borrelia species from the Lyme Borreliosis group. B. miyamotoi was isolated for the first time in Japan in 1995 from I. persulcatus ticks as well as from the blood of Apodemus argentus mice[3, 4], and over recent decades, it has also been detected in Ixodes ticks in Europe, Russia and the USA[5–7]. The first human cases of B. miyamotoi infection were reported in Russia in 2011, and more recently, human infections have been described in the USA and the Netherlands[9–12].
In Europe, Lyme borreliosis is the most common tick-borne disease and is caused by different bacterial species belonging to the Borrelia burgdorferi sensu lato complex. They are transmitted by the tick species which has the most impact on European public health, Ixodes ricinus, and which are hosted by many animal species, like rodents, deer, birds and lizards. In France, over 10,000 new cases of Lyme borreliosis are estimated to occur each year. When there has been a history of tick bites, Lyme disease is commonly assumed, but in some cases there is an absence of diagnostic confirmation. Besides Lyme borreliosis typical cases, diagnosed in its first stage by the presence of an erythema migrans following tick bites and in its later phases by serological tests, a number of patients complain of polymorphic and unspecific clinical symptoms (asthenia, fever, myalgia, etc…), for which the diagnosis is not straightforward. In recent years, unexplained syndromes occurring after tick bite has thus become a very important issue, grown considerably with alternate interpretations of the Lyme disease serology, which has led to considerable unrest between formal institutions of infectious disease and patient associations. The proportion of patients bitten by ticks with unexplained syndromes compared with patients who contracted Lyme disease is difficult to know precisely although it is estimated that 50% of fever after tick bites are of unknown etiological origin. Unexplained syndromes, which have occurred following tick bites have thus become a very important issue in recent years.
In order to better characterize those tick-borne pathogens that are likely to be involved in unexplained tick-borne diseases, we recently generated a global picture of their tick-borne bacteria by analyzing whole transcriptomes of I. ricinus ticks. Surprisingly, we identified the unanticipated B. miyamotoi in I. ricinus collected in France. In the present study, our aim was to investigate the presence and prevalence of B. miyamotoi, along with Lyme borreliosis spirochetes, in both their vectors, i.e., I. ricinus, and their possible animal reservoirs (bank voles, Myodes glareolus). We have established that I. ricinus and bank voles are infected with B. miyamotoi along with Lyme disease spirochetes, that the same B. miyamotoi genotype circulate in both I. ricinus as well as in the bank voles and that this genotype is perfectly identical to those described in Western Europe, including those infecting humans.
Ticks and rodents
Ticks (268 questing Ixodes ricinus female ticks) and bank voles (72 Myodes glareolus) were collected and trapped in the French Ardennes, an endemic region for rodent-borne hantaviruses, along a transect line of about 80 km in the course of a study of the epidemiology of Puumala hantavirus. Along this transect, we sampled six sites in forested areas and four sites in fragmented habitats (i.e. hedge network). Animals were killed by cervical dislocation. They were weighed, sexed and dissected. All collected ticks were washed and crushed as previously described.
Voles genomic DNA was extracted from a piece of spleen using the DNeasy kit (Qiagen) according to manufacturer’s instructions with a final elution volume of 100 μL. Tick genomic DNA was extracted using the Wizard genomic DNA purification kit (Promega) according to manufacturer’s instructions with a final elution volume of 50 μL.
Specific Real-Time PCR for detection and prevalence of Borrelia spp. in ticks and bank voles
Quantitative real-time PCR was performed to determine the prevalence of B. miyamotoi, B. afzelii, B. burgdorferi sensu stricto, B. garinii, B. valaisiana and B. spielmanii using primers and probes described in. A DNA pre-amplification step was performed in a final volume of 5 μl containing 2.5 μl TaqMan PreAmp Master Mix (2X), 1.2 μl of the pooled primer mix (0.2X) and 1.3 μl of ticks or rodent DNA, with one cycle at 95°C for 10 min, 14 cycles at 95°C for 15 sec and 4 min at 60°C. After the pre-amplification PCR, products were diluted 1:20 and stored at -20°C prior to use in qPCR. All fluorogenic probes were synthesized with a 6-carboxy-fluorescein (FAM) reporter molecule attached to the 5’ end and a Black Hole Quencher 1 (BHQ1) attached to the 3’ end. Real-time Taqman PCR assays were performed in a final volume of 12 μl using the LightCycler® 480 Probe Master mix (Roche Applied Science, Germany) at a 1X final concentration, with primers and probes at 200 nM and pre-amplified DNA. Thermal cycling conditions were as follows: 95°C for 5 min, 45 cycles at 95°C for 10s and 60°C for 15 s and then 40°C for 10 s.
Phylogenetic analysis of B. miyamotoi genotypes
Three genomic regions, including partial sequences of 16S rRNA (1256 bp), glpQ (379 bp) and p66 (532 bp) genes were amplified and sequenced as previously described from B. miyamotoi positive-testing tick and rodent DNA extracts. Sequence alignment and phylogenetic analysis was performed using SeaView version 4.4.2 as previously described.
Animals have been treated in accordance with the guidelines of the European Union legislation (Directive 86/609/EEC). The CBGP laboratory has received the approval (no. B 34-169-1) from the regional Head of Veterinary Service (Hérault, France), for the sampling and killing of rodents and the harvesting of their tissues. Dr Cosson has personally received the agreement “certificat d'autorisation d'expérimenter sur animaux vivants” (i.e. “certificate of authorization to experiment on live animals”) (no. C34-105) by the French administration.
Results and discussion
Tick and bank vole DNA samples were assessed for the presence of B. miyamotoi via quantitative real-time PCR using primers and probes described in. The prevalence of B. miyamotoi in ticks and bank voles was 3.0% (8/267 ticks) and 5.55% (4/72) respectively. The prevalence of B. miyamotoi in ticks was similar to that reported for I. ricinus collected from other European countries, which ranged from 0.4% in Estonia to 3.5% in Germany[5, 18]. To our knowledge, this study provides the first estimation of B. miyamotoi DNA prevalence in bank voles. Interestingly, ticks and rodents positive for B. miyamotoi were trapped from very diverse terrains within our study site, including large expanses of forest (near Les Woiries, 49.903°N, 4.766°E; and Renwez, 49.859°N, 4.611°E), forest patches (near La Cassine, 49.575°N, 4.794°E; and Elan 49.653°N, 4.766°E) and hedge networks bordering grasslands (near Sauville, 49.545°N, 4.801°E; Boult-aux-Bois 49.413°N, 4.920°E), also with close proximity to human dwellings in some cases.
In addition to B. miyamotoi, we also detected Lyme spirochetes B. afzelii in 7.11% of ticks and 4.16% of bank voles, and we also found B. burgdorferi sensu stricto, B. garinii, B. valaisiana and B. spielmanii in 1.87%, 9.74%, 5.24% and 1.12% of ticks respectively. Co-infection between B. miyamotoi and B. garinii, was noted in one tick (corresponding to 12.00% [1/8] of B. miyamotoi-infected ticks).
B. miyamotoi has previously been isolated from the blood of different rodent species such as the small Japanese field mouse (Apodemus argentus) from Japan, and the white-footed mouse (Peromyscus leucopus) from the USA, all of these species are likely potential B. miyamotoi host reservoirs. Our results support the importance of different rodent species in the circulation of B. miyamotoi, by adding the bank vole (Myodes glareolus) in the list of potential B. miyamotoi reservoirs in Europe.
In order to better characterize B. miyamotoi genotypes, three genomic regions, including partial sequences of 16S rRNA (1256 bp), glpQ (379 bp) and p66 (532 bp) genes were amplified and sequenced as previously described from positive-testing tick and rodent DNA extracts. All three genes were amplified in all B. miyamotoi positive tick DNA samples, but the 16S RNA gene was amplified in four B. miyamotoi positive bank vole DNA samples, glpQ in only three, and the p66 gene was not amplified at all in bank vole DNA samples.
We have established that B. miyamotoi is present in I. ricinus as well as in the bank vole Myodes glareolus, one of the most important sources of blood meals for I. ricinus larvae. The genotypes of all B. miyamotoi detected in French ticks and rodents were perfectly identical to genotypes already described in ticks from Western Europe, and to the genotype recently isolated from a sick person in the Netherlands. Thus these findings have important implications for public health especially considering that B. miyamotoi-positive ticks and rodents were collected from different terrains, which were sometimes in close proximity to human dwellings. Up until now, no human cases have been reported in France but our data combined with the recent case of human infection described in the Netherlands suggest that surveillance needs to be improved. Symptoms caused by B. miyamotoi could easily be confused with symptoms caused by other pathogens, which are better known by practitioners in our study area, such as Puumala hantavirus or Lyme spirochetes.
In addition, our data suggest that, in the studied area, ticks could simultaneously transmit B. miyamotoi and Lyme disease spirochetes (B. garinii in our case) to humans. This raises the problem of co-infection in humans, a poorly studied issue but with strong potential implications and relevance for public health.
This study was partially funded by the EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext 209 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. This work was also supported by the Metaprogramme MEM of INRA and the COST Action TD1303 (EurNegVec). We thank Emmanuel Guivier, Nathalie Charbonnel, Yannick Chaval, Anne Xuereb and Alexis Ribas-Salvador who helped with the fieldwork. We also thank the group Tiques et Maladies à Tiques (TMT) of the Réseau Ecologie des Interactions Durables (REID) for stimulating discussion and support.
- Franke J, Hildebrandt A, Dorn W: Exploring gaps in our knowledge on Lyme borreliosis spirochaetes–updates on complex heterogeneity, ecology, and pathogenicity. Ticks Tick Borne Dis. 2013, 4 (1–2): 11-25.View ArticlePubMedGoogle Scholar
- Platonov AE, Maleev VV, Karan LS: Relapsing borrelioses fevers: forgotten and new ones. Ter Arkh. 2010, 82 (11): 74-80.PubMedGoogle Scholar
- Fukunaga M, Koreki Y: The flagellin gene of Borrelia miyamotoi sp. nov. and its phylogenetic relationship among Borrelia species. FEMS Microbiol Lett. 1995, 134 (2–3): 255-258.View ArticlePubMedGoogle Scholar
- Fukunaga M, Takahashi Y, Tsuruta Y, Matsushita O, Ralph D, McClelland M, Nakao M: Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Sys Bacteriol. 1995, 45 (4): 804-810. 10.1099/00207713-45-4-804.View ArticleGoogle Scholar
- Richter D, Schlee DB, Matuschka FR: Relapsing fever-like spirochetes infecting European vector tick of Lyme disease agent. Emerg Inf Dis. 2003, 9 (6): 697-701. 10.3201/eid0906.020459.View ArticleGoogle Scholar
- Scoles GA, Papero M, Beati L, Fish D: A relapsing fever group spirochete transmitted by Ixodes scapularis ticks. Vector Borne Zoonotic Dis. 2001, 1 (1): 21-34. 10.1089/153036601750137624.View ArticlePubMedGoogle Scholar
- Fomenko NV, Livanova NN, Borgoiakov V, Kozlova IV, Shulaikina IV, Pukhovskaia NM, Tokarevich KN, Livanov SG, Doroshchenko EK, Ivanov LI: Detection of Borrelia miyamotoi in ticks Ixodes persulcatus from Russia. Parazitologiia. 2010, 44 (3): 201-211.PubMedGoogle Scholar
- Platonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, Maleev VV, Fish D, Krause PJ: Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Inf Dis. 2011, 17 (10): 1816-1823. 10.3201/eid1710.101474.View ArticleGoogle Scholar
- Krause PJ, Narasimhan S, Wormser GP, Rollend L, Fikrig E, Lepore T, Barbour A, Fish D: Human Borrelia miyamotoi infection in the United States. N Engl J Med. 2013, 368 (3): 291-293. 10.1056/NEJMc1215469.PubMed CentralView ArticlePubMedGoogle Scholar
- Chowdri HR, Gugliotta JL, Berardi VP, Goethert HK, Molloy PJ, Sterling SL, Telford SR: Borrelia miyamotoi infection presenting as human granulocytic anaplasmosis: a case report. Ann Intern Med. 2013, 159 (1): 21-27. 10.7326/0003-4819-159-1-201307020-00005.View ArticlePubMedGoogle Scholar
- Gugliotta JL, Goethert HK, Berardi VP, Telford SR: Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. N Engl J Med. 2013, 368 (3): 240-245. 10.1056/NEJMoa1209039.PubMed CentralView ArticlePubMedGoogle Scholar
- Hovius JW, de Wever B, Sohne M, Brouwer MC, Coumou J, Wagemakers A, Oei A, Knol H, Narasimhan S, Hodiamont CJ, Jahfari S, Pals ST, Horlings HM, Fikrig E, Sprong H, van Oers MH: A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe. Lancet. 2013, 382 (9892): 658-10.1016/S0140-6736(13)61644-X.PubMed CentralView ArticlePubMedGoogle Scholar
- Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R: Lyme borreliosis in Europe. Euro Surveill. 2011, 16 (27): 19906-Review. No abstract available. PMID: 21794218 [PubMed - indexed for MEDLINE]PubMedGoogle Scholar
- Baumann D, Pusterla N, Peter O, Grimm F, Fournier PE, Schar G, Bossart W, Lutz H, Weber R: Fever after a tick bite: clinical manifestations and diagnosis of acute tick bite-associated infections in northeastern Switzerland. Dtsch Med Wochenschr. 2003, 128 (19): 1042-1047. 10.1055/s-2003-39103.View ArticlePubMedGoogle Scholar
- Vayssier-Taussat M, Moutailler S, Michelet L, Devillers E, Bonnet S, Cheval J, Hebert C, Eloit M: Next generation sequencing uncovers unexpected bacterial pathogens in ticks in western Europe. PLoS One. 2013, 8 (11): e81439-10.1371/journal.pone.0081439.PubMed CentralView ArticlePubMedGoogle Scholar
- Guivier E, Galan M, Chaval Y, Xuereb A, Ribas Salvador A, Poulle ML, Voutilainen L, Henttonen H, Charbonnel N, Cosson JF: Landscape genetics highlights the role of bank vole metapopulation dynamics in the epidemiology of Puumala hantavirus. Mol Ecol. 2011, 20 (17): 3569-3583.PubMedGoogle Scholar
- Reis C, Cote M, Paul RE, Bonnet S: Questing ticks in suburban forest are infected by at least six tick-borne pathogens. Vector Borne Zoonotic Dis. 2011, 11 (7): 907-916. 10.1089/vbz.2010.0103.View ArticlePubMedGoogle Scholar
- Geller J, Nazarova L, Katargina O, Jarvekulg L, Fomenko N, Golovljova I: Detection and genetic characterization of relapsing fever spirochete Borrelia miyamotoi in Estonian ticks. PLoS One. 2012, 7 (12): e51914-10.1371/journal.pone.0051914.PubMed CentralView ArticlePubMedGoogle Scholar
- Vayssier-Taussat M, Le Rhun D, Buffet JP, Maaoui N, Galan M, Guivier E, Charbonnel N, Cosson JF: Candidatus Neoehrlichia mikurensis in bank voles, France. Emerg Inf Dis. 2012, 18 (12): 2063-2065. 10.3201/eid1812.120846.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.